BIODISCOVERY LLC

BIODISCOVERY LLC specializes in the design, development, and delivery of custom molecular enrichment kits and laboratory reagents for targeted DNA and RNA sequencing applications. Their core expertise lies in probe-based capture technologies, particularly through the MYBAITS platform, enabling high-sensitivity enrichment of genomic regions from degraded or low-yield samples. They engineer biotinylated RNA baits for targeted capture in complex samples, supporting applications in pathogen detection, mitochondrial genomics, and non-model organism research. Their technical proficiency spans oligonucleotide design, assay optimization, and scalable reagent manufacturing, with demonstrated success in delivering bespoke solutions for challenging environmental and forensic samples. A key differentiator is their ability to rapidly prototype and produce custom kits tailored to unique research objectives, from insect vectors to plant pathogens, without reliance on commercial off-the-shelf products. The company maintains a strong, recurring relationship with the Department of Defense, providing mission-critical molecular tools for biothreat detection, forensic identification, and environmental monitoring. They also support the Department of Health and Human Services with diagnostic reagents for parasitic and zoonotic pathogen analysis, and have delivered specialized sequencing kits to the Smithsonian Institution for biodiversity research. Their work with the Department of Agriculture focuses on plant pathogen surveillance using RNA-based enrichment technologies. Their primary industry focus is in research and development within the life sciences, specifically in molecular diagnostics and targeted sequencing enablement. They operate at the intersection of genomics, biochemistry, and analytical instrumentation, serving niche segments in defense biosecurity, public health surveillance, and conservation genomics. BIODISCOVERY LLC is a small business headquartered in Ann Arbor, Michigan, with no federal certifications on record. Their market positioning is defined by technical agility and custom solution development rather than volume production, making them a preferred partner for mission-specific, low-volume, high-complexity genomic tooling needs across federal science and defense agencies.